Details about Sotiris Vandoros

Access statistics for papers by Sotiris Vandoros.

Last updated 2023-11-07. Update your information in the RePEc Author Service.

Short-id: pva780

Working Papers

2021

1. The effect of the Brexit referendum result on subjective well-being*
   LSE Research Online Documents on Economics, London School of Economics and Political Science, LSE Library View citations (5)
   Also in CEP Discussion Papers, Centre for Economic Performance, LSE (2018) View citations (3)
   LSE Research Online Documents on Economics, London School of Economics and Political Science, LSE Library (2018) View citations (4)
   See also Journal Article The effect of the Brexit referendum result on subjective well‐being, Journal of the Royal Statistical Society Series A, Royal Statistical Society (2021) View citations (8) (2021)

2020

2. A Dynamic Ordered Logit Model with Fixed Effects
   Department of Economics Working Papers, McMaster University View citations (5)
   Also in Papers, arXiv.org (2020) View citations (4)
3. Democracy and Health: Evidence from Within-Country Heterogeneity in the Congo
   SocArXiv, Center for Open Science
   See also Journal Article Democracy and health: Evidence from within-country heterogeneity in the Congo, Social Science & Medicine, Elsevier (2017) View citations (1) (2017)

2016

4. Better Health in Times of Hardship?
   Working Papers, Department of Economics, City University London

2014

5. The differential impact of the financial crisis on health in Ireland and Greece: a quasi-experimental approach
   LSE Research Online Documents on Economics, London School of Economics and Political Science, LSE Library View citations (7)

2011

6. Demand and pricing of preventative healthcare
   LSE Research Online Documents on Economics, London School of Economics and Political Science, LSE Library View citations (1)
7. Determinants of branded prescription medicine prices in OECD countries
   LSE Research Online Documents on Economics, London School of Economics and Political Science, LSE Library View citations (14)
   See also Journal Article Determinants of branded prescription medicine prices in OECD countries, Health Economics, Policy and Law, Cambridge University Press (2011) View citations (18) (2011)

Journal Articles

2023

1. Economic uncertainty and cardiovascular disease mortality
   Health Economics, 2023, 32, (7), 1550-1560 View citations (4)
2. Road traffic mortality and economic uncertainty: Evidence from the United States
   Social Science & Medicine, 2023, 326, (C) View citations (1)

2022

3. COVID-19: Early evening curfews and mobility
   Social Science & Medicine, 2022, 292, (C) View citations (3)
4. Police killings and suicide among Black Americans
   Social Science & Medicine, 2022, 305, (C) View citations (1)

2021

5. The effect of the Brexit referendum result on subjective well‐being
   Journal of the Royal Statistical Society Series A, 2021, 184, (2), 707-731 View citations (8)
   See also Working Paper The effect of the Brexit referendum result on subjective well-being*, LSE Research Online Documents on Economics (2021) View citations (5) (2021)

2020

6. Excess mortality during the Covid-19 pandemic: Early evidence from England and Wales
   Social Science & Medicine, 2020, 258, (C) View citations (16)
7. The (Agri-)Cultural origins of obesity
   Social Science & Medicine, 2020, 244, (C)

2019

8. The association between economic uncertainty and suicide in the short-run
   Social Science & Medicine, 2019, 220, (C), 403-410 View citations (30)

2018

9. Healthcare reforms in Cyprus 2013–2017: Does the crisis mark the end of the healthcare sector as we know it?
   Health Policy, 2018, 122, (2), 75-80 View citations (4)
10. The impact of the Great Recession on health-related risk factors, behaviour and outcomes in England
    Social Science & Medicine, 2018, 197, (C), 213-225 View citations (26)

2017

11. Democracy and health: Evidence from within-country heterogeneity in the Congo
    Social Science & Medicine, 2017, 194, (C), 10-16 View citations (1)
    See also Working Paper Democracy and Health: Evidence from Within-Country Heterogeneity in the Congo, SocArXiv (2020) (2020)

2015

12. Cyprus in crisis: Recent changes in the pharmaceutical market and options for further reforms without sacrificing access to or quality of treatment
    Health Policy, 2015, 119, (5), 563-568 View citations (4)

2014

13. Greasy Roads: The Impact of Bad Financial News on Road Traffic Accidents
    Risk Analysis, 2014, 34, (3), 556-566 View citations (16)
14. Parallel Trade and Pharmaceutical Prices: A Game-theoretic Approach and Empirical Evidence from the European Union
    The World Economy, 2014, 37, (6), 856-880 View citations (2)
15. THERAPEUTIC SUBSTITUTION POST‐PATENT EXPIRY: THE CASES OF ACE INHIBITORS AND PROTON PUMP INHIBITORS
    Health Economics, 2014, 23, (5), 621-630 View citations (11)
16. The impact of bank competition and concentration on industrial growth
    Economics Letters, 2014, 124, (1), 60-63 View citations (11)

2013

17. My five pounds are not as good as yours, so I will spend them
    Experimental Economics, 2013, 16, (4), 546-559 View citations (7)
18. Reforms in the Greek pharmaceutical market during the financial crisis
    Health Policy, 2013, 109, (1), 1-6 View citations (17)
19. The generics paradox revisited: empirical evidence from regulated markets
    Applied Economics, 2013, 45, (22), 3230-3239 View citations (16)

2011

20. Determinants of branded prescription medicine prices in OECD countries
    Health Economics, Policy and Law, 2011, 6, (3), 337-367 View citations (18)
    See also Working Paper Determinants of branded prescription medicine prices in OECD countries, LSE Research Online Documents on Economics (2011) View citations (14) (2011)
21. Household expenditures for medicines and the role of free medicines in the brazilian public health system
    American Journal of Public Health, 2011, 101, (5), 916-921 View citations (1)
22. The effects of drug market regulation on pharmaceutical prices in Europe: overview and evidence from the market of ACE inhibitors
    Health Economics Review, 2011, 1, (1), 1-8 View citations (18)

2010

23. Competition in prescription drug markets: is parallel trade the answer?
    Managerial and Decision Economics, 2010, 31, (5), 325-338 View citations (13)